Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Treasury Shares (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Treasury Shares for 7 consecutive years, with $20108.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 51.21% year-over-year to $20108.0, compared with a TTM value of $20108.0 through Dec 2025, down 51.21%, and an annual FY2025 reading of $20108.0, down 51.21% over the prior year.
  • Treasury Shares was $20108.0 for Q4 2025 at aTYR PHARMA, roughly flat from $20108.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $121438.0 in Q2 2022 and bottomed at $7500.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $50717.8, with a median of $41216.0 recorded in 2024.
  • The sharpest move saw Treasury Shares surged 1519.17% in 2022, then plummeted 58.5% in 2024.
  • Year by year, Treasury Shares stood at $7500.0 in 2021, then skyrocketed by 1519.17% to $121438.0 in 2022, then plummeted by 47.85% to $63327.0 in 2023, then plummeted by 34.92% to $41216.0 in 2024, then tumbled by 51.21% to $20108.0 in 2025.
  • Business Quant data shows Treasury Shares for ATYR at $20108.0 in Q4 2025, $20108.0 in Q3 2025, and $20108.0 in Q2 2025.